EUCTR2010-020763-20-GB进行中（未招募）不适用
Hydroxymethylglutaryl-CoA reductase inhibition with simvastatin in Acute lung injury to Reduce Pulmonary dysfunction (HARP 2) - Simvastatin in ALI (HARP 2)
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Patient must be receiving invasive mechanical ventilation 2. Patient must have ALI as defined by acute onset of: a) hypoxic respiratory failure (PaO2/FiO2 = 40 kPa from 2 blood gases >1 hour apart). b) bilateral infiltrates on chest X-ray consistent with pulmonary oedema. c) No clinical evidence of left atrial hypertension or if measured, a pulmonary arterial occlusion pressure (PAOP) less than or equal to 18 mmHg. If a patient has a PAOP > 18 mmHg, then the other criteria must persist for more than 12 hours after the PAOP has declined to < 18 mmHg, and still be within the 48-hour enrolment window Acute onset is defined as follows: the duration of the hypoxia criterion (a) and the chest X-ray criterion (b) must be <28 days at the time of randomisation. Infiltrates considered consistent with pulmonary oedema” include any patchy or diffuse infiltrates not fully explained by mass, atelectasis, or effusion or opacities known to be chronic (>28 days). The findings of vascular redistribution, indistinct vessels, and indistinct cardiac borders are not considered consistent with pulmonary oedema”. All ALI criteria (a-c above) must occur within the same 24 hour period. The time of onset of ALI is when the last ALI criterion is met. Patients must be enrolled within 48 hours of ALI onset
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 0
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 0
排除标准
- •1. Age < 16 years 2. More than 48 hours from the onset of ALI 3. Patient is pregnant 4. CK >10 times the upper limit of the normal range* 5. Transaminases >8 times the upper limit of the normal range* 6. Patients currently receiving ongoing and sustained treatment with any of the following; itraconazole, ketoconazole, HIV protease inhibitors, nefazodone and cyclosporine, amiodarone, verapamil or diltazem. 7. Patients with severe renal impairment (estimated calculated creatinine clearance less than 30ml/minute) not receiving renal replacement therapy 8. Severe liver disease (Child's Pugh score >12; Appendix 1) 9. Current or recent treatment (within 2 weeks) with statins 10. Physician decision that a statin is required for proven indication 11. Contraindication to enteral drug administration 12. Domiciliary mechanical ventilation except for CPAP/BIPAP used for sleep disordered breathing. 13. Participation in other investigational medicinal product (IMP) trials within 30 days 14. Consent declined 15. Treatment withdrawal imminent within 24 hours * If CK, ALT and AST values are not available as part of routine care, a blood sample will be obtained after informed consent but before randomisation. CK, ALT and AST values may be obtained up to 72 hours prior to randomisation.
研究者
相似试验
已完成
2 期
Simvastatin in acute lung injuryLung injuryAcute lung injuryRespiratoryISRCTN88244364Belfast Health and Social Care Trust (UK)540
进行中（未招募）
1 期
Testing if simvastatin reduces delirium - acute confusion - in intensive care patients.DeliriumEUCTR2012-003114-13-GBWest Hertfordshire Hospitals NHS Trust142
进行中（未招募）
1 期
Many patients admitted to the Intensive Care Unit (ICU) have a breathing machine, or ventilator, to help them breathe and ensure that enough oxygen gets into their blood. For reasons that are unclear, when people are critically ill their lungs often fail, which is termed acute lung injury (ALI). This study is being conducted to find out if Simvastatin is effective in the treatment of ALI by testing it in a larger number of patients.Acute lung injuryEUCTR2010-020763-20-IEational University of Ireland, Galway540
已完成
不适用
Hydroxymethylglutaryl-CoA reductase inhibition with simvastatin in Acute lung injury to Reduce Pulmonary dysfunction (HARP)Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS)RespiratoryAcute lung injury and acute respiratory distress syndrome (ARDS)ISRCTN70127774The Royal Group Hospitals Trust (UK)60
已完成
不适用
Modifying Delirium Using SimvastatiTopic: Generic Health Relevance and Cross Cutting ThemesSubtopic: Generic Health Relevance (all Subtopics)Disease: Critical CareMental and Behavioural DisordersPostoperative deliriumISRCTN89079989West Hertfordshire Hospitals NHS Trust (UK)142